Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.

@article{Vickers2013PrognosticFO,
  title={Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.},
  author={Michael M. Vickers and Hulayel Al-Harbi and Toni K Choueiri and Christian K. Kollmannsberger and Scott North and Mary J. Mackenzie and Jennifer J. Knox and Brian I. Rini and Daniel Yick Chin Heng},
  journal={Clinical genitourinary cancer},
  year={2013},
  volume={11 3},
  pages={311-5}
}
BACKGROUND The outcomes and prognosis of patients with brain metastases from advanced renal cell carcinoma (RCC) are not well characterized in the targeted-therapy era. METHODS Data from patients with metastatic RCC (mRCC) and brain metastases treated with targeted therapy were collected through the International Metastatic Renal Cell Carcinoma Database… CONTINUE READING